N. Fallah-rad

发表

The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy

S. Sridhar, S. North, Z. Veitch, 2022, Therapeutic advances in medical oncology.

Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study

T. H. van der Kwast, A. Zlotta, A. Finelli, 2021, PloS one.

Right ventricular dysfunction and injury following marathon running: correlating biomarkers with cardiac MRI

D. Jassal, T. Neilan, N. Mousavi, 2009 .

Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration‐resistant prostate cancer treated with Radium‐223

C. Catton, P. Warde, A. Zlotta, 2021, Cancer medicine.

CKD After 225Ac-PSMA617 Therapy in Patients With Metastatic Prostate Cancer

R. John, A. Kitchlu, N. Fallah-rad, 2020, Kidney international reports.

Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targets.

T. Stockley, P. Bedard, A. Hansen, 2022, Clinical genitourinary cancer.

The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma

A. Hansen, P. Chung, Xuan Li, 2022, British Journal of Cancer.

Relation of biomarkers and cardiac magnetic resonance imaging after marathon running.

D. Jassal, Jonathan R. Walker, T. Neilan, 2009, The American journal of cardiology.

The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.

Pawan K. Singal, D. Jassal, P. Singal, 2011, Journal of the American College of Cardiology.

Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging.

A. R. Summers, D. Jassal, P. Singal, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

D. Jassal, R. Arora, I. Barač, 2009, Breast Cancer Research and Treatment.

Association of Cabozantinib Dose Reductions for Toxicity with Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis)

G. Bjarnason, N. Basappa, S. Tanguay, 2024, Clinical Genitourinary Cancer.

Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study

S. Sridhar, R. Pezo, A. Sacher, 2023, BMJ Open.

Journal of Cardiovascular Magnetic Resonance Open Access Delayed Contrast Enhancement Cardiac Magnetic Resonance Imaging in Trastuzumab Induced Cardiomyopathy

D. Jassal, Tielan Fang, I. Kirkpatrick, 2008 .

Managing hypercalcaemia and hypocalcaemia in cancer patients

N. Fallah-rad, A. Morton, N. Fallah-Rad, 2013, Current opinion in supportive and palliative care.

Association of isocitrate dehydorgenase-1 (IDH-1) mutations with elevated oncometabolite 2-hydroxyglutarate (2HG) in advanced colorectal cancer.

S. Kamel‐Reid, A. Razak, L. Siu, 2016 .